Publications by authors named "Sarah Diab"

Claim this Profile
S
School-Based Nutrition Programs in the Eastern Mediterranean Region: A Systematic Review.
Ayoub Al-Jawaldeh, Dana Matbouli, Sarah Diab, Mandy Taktouk, Leila Hojeij

Int J Environ Res Public Health· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Household Food Insecurity, Anemia, Malnutrition and Unfavorable Dietary Diversity among Adolescents: Quadruple Whammies in the Era of Escalating Crises in Lebanon.
Maha Hoteit, Hala Mohsen, Nour Yazbeck, Sarah Diab, Jessica Sarkis

Nutrients· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Orally Bioavailable and Highly Efficacious Inhibitor of CDK9/FLT3 for the Treatment of Acute Myeloid Leukemia.
Abel Tesfaye Anshabo, Laychiluh Bantie, Sarah Diab, Jimma Lenjisa, Alemwork Kebede

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nutritional status and quality of life in diabetic patients on hemodialysis: a cross-sectional study from Palestine.
Eba'a Hafi, Ro'ya Soradi, Sarah Diab, Ahmad M Samara, Marah Shakhshir

J Health Popul Nutr· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and orally bioavailable CDK8 inhibitors: Design, synthesis, structure-activity relationship analysis and biological evaluation.
Mingfeng Yu, Theodosia Teo, Yuchao Yang, Manjun Li, Yi Long, Sarah Diab

Eur J Med Chem· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success?
Sarah Diab, Mingfeng Yu, Shudong Wang

J Med Chem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of N-Phenyl-4-(1H-pyrrol-3-yl)pyrimidin-2-amine Derivatives as Potent Mnk2 Inhibitors: Design, Synthesis, SAR Analysis, and Evaluation of in vitro Anti-leukaemic Activity.
Ahmed M Abdelaziz, Sarah Diab, Saiful Islam, Sunita K C Basnet, Benjamin Noll

Med Chem· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of CDK5 Inhibitors through Structure-Guided Approach.
Nishat Z Khair, Jimma L Lenjisa, Solomon Tadesse, Malika Kumarasiri, Sunita K C Basnet, Sarah Diab

ACS Med Chem Lett· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial Activity.
Lian Xue, Da-Hua Shi, Jitendra R Harjani, Fei Huang, Julia G Beveridge, Sarah Diab

J Med Chem· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Inhibition of Mnk2 and FLT3 for potential treatment of acute myeloid leukaemia.
Sarah Diab, Ahmad M Abdelaziz, Peng Li, Theodosia Teo, Sunita K C Basnet

Eur J Med Chem· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CDK9: a promising therapeutic opportunity in prostate cancer.
Muhammed H Rahaman, Malika Kumarasiri, Laychiluh B Mekonnen, Mingfeng Yu, Sarah Diab

Endocr Relat Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling new chemical scaffolds as Mnk inhibitors.
Sarah Diab, Peng Li, Sunita K C Basnet, Jingfeng Lu, Mingfeng Yu

Future Med Chem· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cells.
Peng Li, Sarah Diab, Mingfeng Yu, Julian Adams, Saiful Islam

Oncotarget· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a Highly Conserved Allosteric Binding Site on Mnk1 and Mnk2.
Sunita K C Basnet, Sarah Diab, Raffaella Schmid, Mingfeng Yu, Yuchao Yang

Mol Pharmacol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrated approach for discovery of highly potent and selective Mnk inhibitors: Screening, synthesis and SAR analysis.
Theodosia Teo, Yuchao Yang, Mingfeng Yu, Sunita K C Basnet, Todd Gillam, Sarah Diab

Eur J Med Chem· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure-activity relationship analysis and biological evaluation.
Mingfeng Yu, Peng Li, Sunita K C Basnet, Malika Kumarasiri, Sarah Diab

Eur J Med Chem· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 5-(2-(phenylamino)pyrimidin-4-yl)thiazol-2(3H)-one derivatives as potent Mnk2 inhibitors: synthesis, SAR analysis and biological evaluation.
Sarah Diab, Theodosia Teo, Malika Kumarasiri, Peng Li, Mingfeng Yu

ChemMedChem· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAP kinase-interacting kinases--emerging targets against cancer.
Sarah Diab, Malika Kumarasiri, Mingfeng Yu, Theodosia Teo, Christopher Proud

Chem Biol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of (E)-3-((styrylsulfonyl)methyl)pyridine and (E)-2-((styrylsulfonyl)methyl)pyridine derivatives as anticancer agents: synthesis, structure-activity relationships, and biological activities.
Tiangong Lu, Aik Wye Goh, Mingfeng Yu, Julian Adams, Frankie Lam, Sarah Diab

J Med Chem· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis